EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Immunotherapy biomarkers in brain metastases: insights into tumor microenvironment dynamics

Mu Li, Yi Zhang, Duo Yu, Yaoyu Yu, Wenxue Ma

Frontiers in Immunology · 13.08.2025 · 16

DOI: 10.3389/fimmu.2025.1600261 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Immunology, online erschienen am 13.08.2025. Verfasst von Mu Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Dengzhou People's Hospital, Dengzhou, Henan, China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Immunotherapy, Brain Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 156 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Brain metastases (BM), represent the most common intracranial malignancies in adults and remain a major clinical challenge due to their poor prognosis and limited therapeutic options. Although immunotherapy has emerged and offers a promising strategy, its efficacy in BM is often compromised by the immunosuppressive tumor microenvironment (TME) and limited immune cell infiltration. This review highlights the critical role of cytokines and growth factors as key modulators of immune dynamics in the TME, exploring their utility as predictive and prognostic biomarkers for immune response. We examine selected categories of biomarkers including genomic, proteomic, immunological, circulating, and microenvironmental, specifically through the lens of cytokine and growth factor regulation. Additionally, we highlight how advanced technologies, including next-generation sequencing (NGS), single-cell RNA sequencing (scRNA-seq), spatial transcriptomics, and liquid biopsies, contribute to the identification and validation of these biomarkers. By addressing current challenges and proposing future directions, this review underscores the translational value of cytokine- and growth factor-related biomarkers in optimizing precision immunotherapy for patient s with BM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentImmunotherapyBrain NeoplasmsBiomarkers, TumorHumansCytokinesAnimalsPrognosis

Stichwörter der Autor:innen

biomarkersbrain metastasescytokinesimmunotherapytranscriptomicstumor microenvironment (TME)

Substanzen

Biomarkers, TumorCytokines

Autor:innen und Institutionen

  • Department of Neurosurgery, Dengzhou People's Hospital, Dengzhou, Henan, China.
  • Department of Biopharmaceutics, School of Pharmacy, Air Force Medical University, Xi'an, China.
  • Department of Neurosurgery, Brain Hospital Affiliated to Tongji University, Shanghai, China.
  • Department of Medicine, Sanford Stem Cell Institute, and Moores Cancer Center, University of California San Diego, La Jolla, CA, United States.

Zitieren

APA

Li, M., Zhang, Y., Yu, D., Yu, Y., & Ma, W. (2025). Immunotherapy biomarkers in brain metastases: insights into tumor microenvironment dynamics. Frontiers in Immunology, 16. https://doi.org/10.3389/fimmu.2025.1600261

Vancouver

Li M, Zhang Y, Yu D, Yu Y, Ma W. Immunotherapy biomarkers in brain metastases: insights into tumor microenvironment dynamics. Frontiers in Immunology. 2025;16. doi:10.3389/fimmu.2025.1600261

BibTeX
@article{Li2025,
  author = {Li, Mu and Zhang, Yi and Yu, Duo and Yu, Yaoyu and Ma, Wenxue},
  title = {Immunotherapy biomarkers in brain metastases: insights into tumor microenvironment dynamics},
  journal = {Frontiers in Immunology},
  year = {2025},
  volume = {16},
  doi = {10.3389/fimmu.2025.1600261}
}
Kostenlos starten →